Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunoglobulin Prophylaxis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02991872
What this trial is testing

Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children

Who this might be right for
Virus Diseases
GlaxoSmithKline 150
Testing effectiveness (Phase 2)Study completedNCT02690038
What this trial is testing

Ig PRx in AECOPD: Pilot Study

Who this might be right for
Chronic Obstructive Pulmonary Disease
Ottawa Hospital Research Institute 48
Testing effectiveness (Phase 2)Study completedNCT01228383
What this trial is testing

Rabies Virus Neutralizing Activity and Safety of CL184, a Monoclonal Antibody Cocktail, in Simulated Rabies Post-Exposure Prophylaxis in Healthy Adults

Who this might be right for
Rabies
Crucell Holland BV 240
Large-scale testing (Phase 3)Looking for participantsNCT07626411
What this trial is testing

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation (AF)
Regeneron Pharmaceuticals 15,364
Early research (Phase 1)Study completedNCT04206332
What this trial is testing

Trial to Evaluate CIS43LS in Healthy Adults

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 71
Large-scale testing (Phase 3)Study completedNCT00129766
What this trial is testing

Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children

Who this might be right for
Respiratory Syncytial Virus Infections
MedImmune LLC 6,635
Large-scale testing (Phase 3)Ended earlyNCT05331885
What this trial is testing

A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2

Who this might be right for
Ventilator Associated PneumoniaStaphylococcus Aureus
Aridis Pharmaceuticals, Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT05027906
What this trial is testing

Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant

Who this might be right for
Prevention of Rejection in Kidney Transplant
Eledon Pharmaceuticals 48
Large-scale testing (Phase 3)UnknownNCT03200561
What this trial is testing

A Trial to Evaluate the Efficacy of Immunoglobulin Plus Steroid for Prevention of Coronary Artery Abnormalities in Taiwanese Refractory Kawasaki Disease (RAST Study)

Who this might be right for
Kawasaki DiseaseSteroidImmuoglobulin
National Taiwan University Hospital 100
Not applicableStudy completedNCT05197673
What this trial is testing

Identifying Risks of COVID-19 Outbreaks in Work Settings and the Implications for Control Measures

Who this might be right for
Intention to Get SARS-CoV-2 VaccinationIntention to Get SARS-CoV-2 Antibody Test
Chinese University of Hong Kong 310
Not applicableUnknownNCT05232942
What this trial is testing

Monoclonal Antibody Duration of REsponse in MIgraine After Treatment Interruption

Who this might be right for
MigraineHeadache, Migraine
Hospital Clínico Universitario de Valladolid 200
Early research (Phase 1)Ended earlyNCT05135650
What this trial is testing

Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Fred Hutchinson Cancer Center 20
Early research (Phase 1)Study completedNCT04408963
What this trial is testing

Trial to Evaluate CAP256V2LS in Healthy Adults

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07744919
What this trial is testing

Severe Hepatitis Intervention With Emapalumab for Liver Disease

Who this might be right for
Hepatitis
Children's Healthcare of Atlanta 28
Not applicableStudy completedNCT02043379
What this trial is testing

Post-bypass Prophylactic IVIG in Infants and Neonates

Who this might be right for
HypogammaglobulinemiaCongenital Heart Disease
University of Alabama at Birmingham 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05453435
What this trial is testing

Entecavir Prophylaxis for Hepatitis B Reactivation for CD20 Positive B-cell Lymphoma Patients With Resolved Hepatitis B (Negative Hepatitis B Surface Antigen, Positive Hepatitis B Core Antibody)

Who this might be right for
Resolved Hepatitis BCD20 Positive B-cell Lymphoma
Sun Yat-sen University 84
Early research (Phase 1)Study completedNCT05891236
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults

Who this might be right for
Malaria
Gates Medical Research Institute 63
Testing effectiveness (Phase 2)Looking for participantsNCT06976476
What this trial is testing

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

Who this might be right for
Multiple MyelomaHypogammaglobulinemiaHypogammaglobulinemia, Acquired
Memorial Sloan Kettering Cancer Center 100
Large-scale testing (Phase 3)Study completedNCT00121108
What this trial is testing

MEDI-524 (Motavizumab) for the Prevention of Respiratory Sycytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States

Who this might be right for
Healthy
MedImmune LLC 2,127
Testing effectiveness (Phase 2)Active Not RecruitingNCT05034536
What this trial is testing

PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Massachusetts General Hospital 36
Next Page